References
Abuqwider, J. N., Mauriello, G., &
Altamimi, M. (2021). Akkermansia muciniphila, a New Generation of
Beneficial Microbiota in Modulating Obesity: A Systematic Review.Microorganisms, 9 (5). doi: 10.3390/microorganisms9051098
Anderson, Per, Carrillo-Gálvez, Ana
Belén, & Martín, Francisco. (2015). Isolation of Murine Adipose
Tissue-derived Mesenchymal Stromal Cells (mASCs) and the Analysis of
Their Proliferation in vitro. Bio-protocol, 5 (21), e1642. doi:
10.21769/BioProtoc.1642
Boone, D.R., Castenholz, R., &
Garrity, G. . (2001). Bergey’s Manual of Systematic Bacteriology.Springer–Verlag .
Braunersreuther, V., Viviani, G. L.,
Mach, F., & Montecucco, F. (2012). Role of cytokines and chemokines in
non-alcoholic fatty liver disease. World J Gastroenterol, 18 (8),
727-735. doi: 10.3748/wjg.v18.i8.727
Budhwar, S., Verma, P., Verma, R.,
Rai, S., & Singh, K. (2018). The Yin and Yang of Myeloid Derived
Suppressor Cells. Front Immunol, 9 , 2776. doi:
10.3389/fimmu.2018.02776
Cipolla-Neto, J., Amaral, F. G.,
Afeche, S. C., Tan, D. X., & Reiter, R. J. (2014). Melatonin, energy
metabolism, and obesity: a review. J Pineal Res, 56 (4), 371-381.
doi: 10.1111/jpi.12137
Crovesy, L., Masterson, D., & Rosado,
E. L. (2020). Profile of the gut microbiota of adults with obesity: a
systematic review. Eur J Clin Nutr, 74 (9), 1251-1262. doi:
10.1038/s41430-020-0607-6
Cherngwelling, R., Pengrattanachot,
N., Swe, M. T., Thongnak, L., Promsan, S., Phengpol, N., et al .
(2021). Agomelatine protects against obesity-induced renal injury by
inhibiting endoplasmic reticulum stress/apoptosis pathway in rats.Toxicol Appl Pharmacol, 425 , 115601. doi:
10.1016/j.taap.2021.115601
de Farias, Tdsm, Cruz, M. M., de Sa,
Rcdc, Severi, I., Perugini, J., Senzacqua, M., et al . (2019).
Melatonin Supplementation Decreases Hypertrophic Obesity and
Inflammation Induced by High-Fat Diet in Mice. Front Endocrinol
(Lausanne), 10 , 750. doi: 10.3389/fendo.2019.00750
Farias, T., Paixao R.I.D., Cruz M.M., de Sa R., Simao, J.J., Antraco,
V.J., Alonso-Vale, M.I.C. Melatonin Supplementation Attenuates the
Pro-Inflammatory Adipokines Expression in Visceral Fat from Obese Mice
Induced by A High-Fat Diet, Cells 8(9) (2019).
Dhariwal, A., Chong, J., Habib, S.,
King, I. L., Agellon, L. B., & Xia, J. (2017). MicrobiomeAnalyst: a
web-based tool for comprehensive statistical, visual and meta-analysis
of microbiome data. Nucleic Acids Res, 45 (W1), W180-W188. doi:
10.1093/nar/gkx295
Diez-Echave, P., Vezza, T.,
Rodriguez-Nogales, A., Ruiz-Malagon, A. J., Hidalgo-Garcia, L.,
Garrido-Mesa, J., et al . (2020). The prebiotic properties of
Hibiscus sabdariffa extract contribute to the beneficial effects in
diet-induced obesity in mice. Food Res Int, 127 , 108722. doi:
10.1016/j.foodres.2019.108722
Ellulu, M. S., Patimah, I., Khaza’ai,
H., Rahmat, A., & Abed, Y. (2017). Obesity and inflammation: the
linking mechanism and the complications. Arch Med Sci, 13 (4),
851-863. doi: 10.5114/aoms.2016.58928
Farias, Tdsm, Paixao, R. I. D., Cruz,
M. M., de Sa, Rdcdc, Simao, J. J., Antraco, V. J., & Alonso-Vale, M. I.
C. (2019). Melatonin Supplementation Attenuates the Pro-Inflammatory
Adipokines Expression in Visceral Fat from Obese Mice Induced by A
High-Fat Diet. Cells, 8 (9). doi: 10.3390/cells8091041
Ferreira-Hermosillo, A.,
Molina-Ayala, M. A., Molina-Guerrero, D., Garrido-Mendoza, A. P.,
Ramirez-Renteria, C., Mendoza-Zubieta, V., et al. (2020).
Efficacy of the treatment with dapagliflozin and metformin compared to
metformin monotherapy for weight loss in patients with class III
obesity: a randomized controlled trial. Trials, 21 (1), 186. doi:
10.1186/s13063-020-4121-x
Genario, R., Cipolla-Neto, J., Bueno,
A. A., & Santos, H. O. (2021). Melatonin supplementation in the
management of obesity and obesity-associated disorders: A review of
physiological mechanisms and clinical applications. Pharmacol Res,
163 , 105254. doi: 10.1016/j.phrs.2020.105254
Gonzalez, F. J., & Jiang, C. (2017).
A Western diet-induced mouse model reveals a possible mechanism by which
metformin decreases obesity. Eur J Clin Pharmacol, 73 (10),
1337-1339. doi: 10.1007/s00228-017-2322-3
Gorwood, P., Benichou, J., Moore, N.,
Wattez, M., Secouard, M. C., Desobry, X., et al . (2020).
Agomelatine in Standard Medical Practice in Depressed Patients: Results
of a 1-Year Multicentre Observational Study In France. Clin Drug
Investig, 40 (11), 1009-1020. doi: 10.1007/s40261-020-00957-9
Greenblum, S., Turnbaugh, P. J., &
Borenstein, E. (2012). Metagenomic systems biology of the human gut
microbiome reveals topological shifts associated with obesity and
inflammatory bowel disease. Proc Natl Acad Sci U S A, 109 (2),
594-599. doi: 10.1073/pnas.1116053109
Hayashi, T., Fujita, K., Matsushita,
M., Hayashi, Y., Uemura, M., & Nonomura, N. (2019). Metformin inhibits
prostate cancer growth induced by a high-fat diet in Pten-deficient
model mice. Int J Urol, 26 (2), 307-309. doi: 10.1111/iju.13847
Henagan, T. M., Stefanska, B., Fang,
Z., Navard, A. M., Ye, J., Lenard, N. R., & Devarshi, P. P. (2015).
Sodium butyrate epigenetically modulates high-fat diet-induced skeletal
muscle mitochondrial adaptation, obesity and insulin resistance through
nucleosome positioning. Br J Pharmacol, 172 (11), 2782-2798. doi:
10.1111/bph.13058
Hickie, I. B., & Rogers, N. L.
(2011). Novel melatonin-based therapies: potential advances in the
treatment of major depression. Lancet, 378 (9791), 621-631. doi:
10.1016/S0140-6736(11)60095-0
Hussain, M. M., & Pan, X. (2012).
Clock regulation of dietary lipid absorption. Curr Opin Clin Nutr
Metab Care, 15 (4), 336-341. doi: 10.1097/MCO.0b013e3283548629
Ji, S., Wang, L., & Li, L. (2019).
Effect of Metformin on Short-Term High-Fat Diet-Induced Weight Gain and
Anxiety-Like Behavior and the Gut Microbiota. Front Endocrinol
(Lausanne), 10 , 704. doi: 10.3389/fendo.2019.00704
Le Chatelier, E., Nielsen, T., Qin,
J., Prifti, E., Hildebrand, F., Falony, G., et al . (2013).
Richness of human gut microbiome correlates with metabolic markers.Nature, 500 (7464), 541-546. doi: 10.1038/nature12506
Lee, Y. H., Giraud, J., Davis, R. J.,
& White, M. F. (2003). c-Jun N-terminal kinase (JNK) mediates feedback
inhibition of the insulin signaling cascade. J Biol Chem, 278 (5),
2896-2902. doi: 10.1074/jbc.M208359200
Li, Y., Ma, J., Yao, K., Su, W., Tan,
B., Wu, X., et al . (2020). Circadian rhythms and obesity:
Timekeeping governs lipid metabolism. J Pineal Res, 69 (3),
e12682. doi: 10.1111/jpi.12682
Liu, G., Jiang, Q., Chen, S., Fang,
J., Ren, W., Yin, J., et al . (2017). Melatonin alters amino acid
metabolism and inflammatory responses in colitis mice. Amino
Acids, 49 (12), 2065-2071. doi: 10.1007/s00726-017-2489-z
Loloei, S., Sepidarkish, M.,
Heydarian, A., Tahvilian, N., Khazdouz, M., Heshmati, J., & Pouraram,
H. (2019). The effect of melatonin supplementation on lipid profile and
anthropometric indices: A systematic review and meta-analysis of
clinical trials. Diabetes Metab Syndr, 13 (3), 1901-1910. doi:
10.1016/j.dsx.2019.04.043
Louis, P., & Flint, H. J. (2017).
Formation of propionate and butyrate by the human colonic microbiota.Environ Microbiol, 19 (1), 29-41. doi: 10.1111/1462-2920.13589
Lu, Q., Li, X., Liu, J., Sun, X.,
Rousselle, T., Ren, D., et al . (2019). AMPK is associated with
the beneficial effects of antidiabetic agents on cardiovascular
diseases. Biosci Rep, 39 (2). doi: 10.1042/BSR20181995
Luther, J., Garber, J. J., Khalili,
H., Dave, M., Bale, S. S., Jindal, R., et al. (2015). Hepatic
Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal
Permeability. Cell Mol Gastroenterol Hepatol, 1 (2), 222-232. doi:
10.1016/j.jcmgh.2015.01.001
Mantele, S., Otway, D. T., Middleton,
B., Bretschneider, S., Wright, J., Robertson, M. D., et al .
(2012). Daily rhythms of plasma melatonin, but not plasma leptin or
leptin mRNA, vary between lean, obese and type 2 diabetic men.PLoS One, 7 (5), e37123. doi: 10.1371/journal.pone.0037123
Milano, W., De Rosa, M., Milano, L.,
Riccio, A., Sanseverino, B., & Capasso, A. (2013). Successful Treatment
with Agomelatine in NES: A Series of Five Cases. Open Neurol J,
7 , 32-37. doi: 10.2174/1874205X20130626001
Muscogiuri, G., Cantone, E.,
Cassarano, S., Tuccinardi, D., Barrea, L., Savastano, S., et al .
(2019). Gut microbiota: a new path to treat obesity. Int J Obes
Suppl, 9 (1), 10-19. doi: 10.1038/s41367-019-0011-7
Nogueira, T. C., Lellis-Santos, C.,
Jesus, D. S., Taneda, M., Rodrigues, S. C., Amaral, F. G., et al.(2011). Absence of melatonin induces night-time hepatic insulin
resistance and increased gluconeogenesis due to stimulation of nocturnal
unfolded protein response. Endocrinology, 152 (4), 1253-1263. doi:
10.1210/en.2010-1088
O’Neill, L. A., & Hardie, D. G.
(2013). Metabolism of inflammation limited by AMPK and
pseudo-starvation. Nature, 493 (7432), 346-355. doi:
10.1038/nature11862
Pu, R., Shi, D., Gan, T., Ren, X.,
Ba, Y., Huo, Y., et al. (2020). Effects of metformin in obesity
treatment in different populations: a meta-analysis. Ther Adv
Endocrinol Metab, 11 , 2042018820926000. doi: 10.1177/2042018820926000
Rebai, R., Jasmin, L., & Boudah, A.
(2021). Agomelatine effects on fat-enriched diet induced
neuroinflammation and depression-like behavior in rats. Biomed
Pharmacother, 135 , 111246. doi: 10.1016/j.biopha.2021.111246
Reiter, R. J., Tamura, H., Tan, D.
X., & Xu, X. Y. (2014). Melatonin and the circadian system:
contributions to successful female reproduction. Fertil Steril,
102 (2), 321-328. doi: 10.1016/j.fertnstert.2014.06.014
Ren, W., Wang, P., Yan, J., Liu, G.,
Zeng, B., Hussain, T., et al . (2018). Melatonin alleviates
weanling stress in mice: Involvement of intestinal microbiota. J
Pineal Res, 64 (2). doi: 10.1111/jpi.12448
Rodriguez-Nogales, A., Algieri, F.,
Garrido-Mesa, J., Vezza, T., Utrilla, M. P., Chueca, N., et al.(2017). Differential intestinal anti-inflammatory effects of
Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse
colitis: impact on microRNAs expression and microbiota composition.Mol Nutr Food Res, 61 (11). doi: 10.1002/mnfr.201700144
Rovella, V., Rodia, G., Di Daniele,
F., Cardillo, C., Campia, U., Noce, A., et al. (2021).
Association of Gut Hormones and Microbiota with Vascular Dysfunction in
Obesity. Nutrients, 13 (2). doi: 10.3390/nu13020613
Ruderman, N. B., Carling, D.,
Prentki, M., & Cacicedo, J. M. (2013). AMPK, insulin resistance, and
the metabolic syndrome. J Clin Invest, 123 (7), 2764-2772. doi:
10.1172/JCI67227
Salminen, A., Hyttinen, J. M., &
Kaarniranta, K. (2011). AMP-activated protein kinase inhibits NF-kappaB
signaling and inflammation: impact on healthspan and lifespan. J
Mol Med (Berl), 89 (7), 667-676. doi: 10.1007/s00109-011-0748-0
Sharma, Mala, McClung, John Arthur,
& Abraham, Nader G. (2016). Chapter 4 - Adiponectin: A Mediator of
Obesity, Insulin Resistance, Diabetes, and the Metabolic Syndrome. In W.
S. Aronow & J. A. McClung (Eds.), Translational Research in
Coronary Artery Disease (pp. 33-42). Boston: Academic Press.
Shen, J., Obin, M. S., & Zhao, L.
(2013). The gut microbiota, obesity and insulin resistance. Mol
Aspects Med, 34 (1), 39-58. doi: 10.1016/j.mam.2012.11.001
Sundara Rajan, S., & Longhi, M. P.
(2016). Dendritic cells and adipose tissue. Immunology, 149 (4),
353-361. doi: 10.1111/imm.12653
Targher, G., Byrne, C. D., Lonardo,
A., Zoppini, G., & Barbui, C. (2016). Non-alcoholic fatty liver disease
and risk of incident cardiovascular disease: A meta-analysis. J
Hepatol, 65 (3), 589-600. doi: 10.1016/j.jhep.2016.05.013
Teixeira, T. F., Souza, N. C.,
Chiarello, P. G., Franceschini, S. C., Bressan, J., Ferreira, C. L., &
Peluzio Mdo, C. (2012). Intestinal permeability parameters in obese
patients are correlated with metabolic syndrome risk factors. Clin
Nutr, 31 (5), 735-740. doi: 10.1016/j.clnu.2012.02.009
WHO. (2019). Obesity and Overweight,
World Health Organization.
Wong, J. M., de Souza, R., Kendall,
C. W., Emam, A., & Jenkins, D. J. (2006). Colonic health: fermentation
and short chain fatty acids. J Clin Gastroenterol, 40 (3),
235-243. doi: 10.1097/00004836-200603000-00015
Woo, S. L., Xu, H., Li, H., Zhao, Y.,
Hu, X., Zhao, J., et al. (2014). Metformin ameliorates hepatic
steatosis and inflammation without altering adipose phenotype in
diet-induced obesity. PLoS One, 9 (3), e91111. doi:
10.1371/journal.pone.0091111
Wu, S. J., Huang, W. C., Yu, M. C.,
Chen, Y. L., Shen, S. C., Yeh, K. W., & Liou, C. J. (2021). Tomatidine
ameliorates obesity-induced nonalcoholic fatty liver disease in mice.J Nutr Biochem, 91 , 108602. doi: 10.1016/j.jnutbio.2021.108602
Xu, P., Yin, K., Tang, X., Tian, J.,
Zhang, Y., Ma, J., et al. (2019). Metformin inhibits the function
of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.Biomed Pharmacother, 120 , 109458. doi:
10.1016/j.biopha.2019.109458
Yadav, A., Kataria, M. A., Saini, V.,
& Yadav, A. (2013). Role of leptin and adiponectin in insulin
resistance. Clin Chim Acta, 417 , 80-84. doi:
10.1016/j.cca.2012.12.007
Yin, J., Li, Y., Han, H., Chen, S.,
Gao, J., Liu, G., et al. (2018). Melatonin reprogramming of gut
microbiota improves lipid dysmetabolism in high-fat diet-fed mice.J Pineal Res, 65 (4), e12524. doi: 10.1111/jpi.12524
Zhang, H. M., & Zhang, Y. (2014).
Melatonin: a well-documented antioxidant with conditional pro-oxidant
actions. J Pineal Res, 57 (2), 131-146. doi: 10.1111/jpi.12162
Zhang, Q., & Hu, N. (2020). Effects
of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes
Mellitus. Diabetes Metab Syndr Obes, 13 , 5003-5014. doi:
10.2147/DMSO.S286430